Stay updated on Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new deployment of the study record page. This reflects a backend update rather than changes to the study content or eligibility criteria.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, indicating a new build of the page template. This appears to be an internal deployment rather than a modification to study information or visible content.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page shows a new build revision (v3.6.4) replacing the previous revision (v3.6.3), indicating an underlying update to the site's framework or content delivery. It does not alter the study details or visible information presented to users.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous v3.6.0. This appears to be a software/template release update and does not modify the trial data presented.SummaryDifference0.0%

- Check79 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting was updated from 'Intervention / Treatment' to 'Intervention/Treatment', with a new page revision marker (Revision: v3.6.0). The recruitment status now indicates no further participants are being sought.SummaryDifference0.4%

Stay in the know with updates to Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.